Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment
出版年份 2011 全文链接
标题
Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment
作者
关键词
-
出版物
Immunotherapy
Volume 3, Issue 8, Pages 933-944
出版商
Future Medicine Ltd
发表日期
2011-08-16
DOI
10.2217/imt.11.87
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A phase Ib safety and pharmacokinetic study of bavituximab plus chemotherapy in patients with refractory advanced solid tumor malignancies
- (2017) R. Digumarti et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized phase II trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C), paclitaxel (P), and bevacizumab (B) in stage IIIb/IV nonsquamous non-small cell lung cancer (NSCLC): The FALCON trial.
- (2017) E. B. Garon et al. JOURNAL OF CLINICAL ONCOLOGY
- Abstract 621: Targeting phosphatidylserine to improve androgen deprivation therapy of prostate cancer
- (2012) Yi Yin et al. CANCER RESEARCH
- Treatment-Related Mortality With Bevacizumab in Cancer Patients
- (2011) Vishal Ranpura et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Disrupting established tumor blood vessels
- (2010) Mark J. McKeage et al. CANCER
- MAGE A3 antigen-specific cancer immunotherapeutic
- (2010) Nir Peled et al. Immunotherapy
- Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
- (2010) Giorgio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines
- (2010) M. Anthony Moody et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey
- (2010) Daniel Morgensztern et al. Journal of Thoracic Oncology
- Looking Beyond Surveillance, Epidemiology, and End Results: Patterns of Chemotherapy Administration for Advanced Non-small Cell Lung Cancer in a Contemporary, Diverse Population
- (2010) Drew W. Rasco et al. Journal of Thoracic Oncology
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting anionic phospholipids on tumor blood vessels and tumor cells
- (2010) Philip E. Thorpe THROMBOSIS RESEARCH
- Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
- (2009) V Gregorc et al. BRITISH JOURNAL OF CANCER
- Antiphosphatidylserine Antibody Combined with Irradiation Damages Tumor Blood Vessels and Induces Tumor Immunity in a Rat Model of Glioblastoma
- (2009) J. He et al. CLINICAL CANCER RESEARCH
- Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours
- (2009) Vanesa Gregorc et al. EUROPEAN JOURNAL OF CANCER
- Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors
- (2009) Roy S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab
- (2009) David R. Spigel et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study
- (2009) Glenwood D. Goss et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m2 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer
- (2009) Mark J. McKeage et al. LUNG CANCER
- Vascular Disrupting Agents: A Novel Mechanism of Action in the Battle Against Non-Small Cell Lung Cancer
- (2009) C. Gridelli et al. ONCOLOGIST
- Coincident exposure of phosphatidylethanolamine and anionic phospholipids on the surface of irradiated cells
- (2008) Andrei Marconescu et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer
- (2008) M J McKeage et al. BRITISH JOURNAL OF CANCER
- EGFR inhibition in the treatment of non-small cell lung cancer
- (2008) David E. Gerber DRUG DEVELOPMENT RESEARCH
- Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases
- (2008) M Melina Soares et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started